Note to our followers: Due to a lack of sufficient funding, will cease daily publication of new content at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. If you wish to donate, your gift might help keep the site available to the public for a few more years, by defraying costs of web hosting and maintenance. All of our 6,000+ published articles contain lessons to help people improve their critical thinking about health care. Read more about our change in status. And here's how to make a donation.

Podcast: The problematic promise of a ‘cure’ for Alzheimer’s disease

Michael Joyce is a writer-producer with and tweets as @mlmjoyce

Click here to read more stories about real people harmed by misleading messages, or share your own story.

Alzheimer’s is a disease in which the cause is unknown, and a treatment hasn’t been found.

Despite this, the Alzheimer’s Association features fundraising commercials that promise “breakthroughs … a cure … (and) the first person to survive Alzheimer’s disease is out there.”

In this podcast we explore whether such promises are irresponsible, unethical, and potentially harmful. You’ll hear from: A gerontologist, a bioethicist ,a geriatric neurologist, and three people whose lives have been deeply impacted by the disease.

Over the past 12+ years we’ve written 200+ articles related to Alzheimer’s disease.

For a condition in which the risk factors are unclear, the cause or causes unknown, and the near-term prospects for slowing or halting its progression unlikely … it certainly generates a mind-boggling amount of hyperbolic news coverage. Some of the most misleading seems to fall into these categories:

And that’s just a very, very partial list. That’s why we created this resource for journalists:

5 questions to ask when writing (and reading) about new Alzheimer’s drug research

There are some ideas and themes mentioned in the podcast you may want to dig into deeper. These links will be a good starting point:

You can find a full listing of all our podcasts HERE


We Welcome Comments. But please note: We will delete comments left by anyone who doesn’t leave an actual first and last name and an actual email address.

We will delete comments that include personal attacks, unfounded allegations, unverified facts, product pitches, or profanity. We will also end any thread of repetitive comments. Comments should primarily discuss the quality (or lack thereof) in journalism or other media messages about health and medicine. This is not intended to be a forum for definitive discussions about medicine or science. Nor is it a forum to share your personal story about a disease or treatment -- your comment must relate to media messages about health care. If your comment doesn't adhere to these policies, we won't post it. Questions? Please see more on our comments policy.